.png)
Transaction |
2024
PCM Trials acquires CTS
US-based PCM Trials acquired Netherlands-based Clinical Trial Service, combining their mobile clinical research capabilities across international markets.
.png){kind=logo}
Client
CTS
Other party
PCM Trials
Advisor
Transition Corporate Finance
Geography
Netherlands, United States
Sector
Healthcare
The transaction
Clinical Trial Service is a Netherlands-based healthcare company with more than 30 years’ experience managing and staffing global clinical trials through mobile research nurses. Its model helps pharmaceutical sponsors and contract research organisations deliver decentralised studies while addressing local market, cultural and regulatory requirements.
Transition Corporate Finance acted as exclusive M&A advisor to the seller on the acquisition by US-based PCM Trials, a specialist provider of mobile research nurses for decentralised clinical trials. The combined organisation can support complex studies in more than 80 countries, strengthening geographic coverage and the ability to serve international programmes. CTS continues to operate under its existing brand, with founder Mirjam Bruggink remaining involved to support a smooth transition.
At a glance
Transaction type
Sell-side M&A
Industry
Healthcare
Value
Undisclosed
Completion
2024
Cross-border context
The transaction connected a Dutch clinical-research services business with a US provider of decentralised clinical-trial support. Transition Corporate Finance helped position the company’s specialist capabilities for an international healthcare acquirer.
Advising firm
Transition Corporate Finance
Amsterdam
Netherlands
Transition Corporate Finance is an independent corporate finance boutique specialising in mergers and acquisitions and strategic financial advice.
Based in Amsterdam, the firm operates in the Dutch and international mid-market, focusing on transactions of approximately €5 million to €100 million and above. Its approach combines a thorough understanding of each business with proactive advice shaped around its strategic objectives.
